NYSE · NHI

National Health Investors

$79.28 -$1.26 (-1.56%) 1D After hours
Session Pulse Overnight session 1 mentions on Mon No new SEC filings since Tue close its sector ranked 4/11 this week Full pulse →

Key Metrics

$3.90B
Market cap
26.36×
P/E · TTM
$401.46M
Revenue · TTM
$148.11M
Net income
EPS · TTM $3.23
Dividend yield 4.4%
Free cash flow
Beta · 1Y -0.31
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    A material event was filed (Form 8-K).

    8-K - NATIONAL HEALTH INVESTORS INC (0000877860) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Apr 22
    The stock moved -8.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 22

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$3.90B
Enterprise value
Shares outstanding48.5M
52-wk range$67.94 – $91.38
Avg volume · 20D266.7K
Net cash
Book value / share$33.02
IndustryReal Estate Investment Trusts
ExchangeNYSE
About National Health Investors
IPO dateOct 17, 1991
Employees32

National Health Investors Inc is a self-managed REIT that owns, leases, operates, and finances the development of senior housing communities and medical facilities. It operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio (SHOP).

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E26.36
P/S9.72
P/FCF
EV/EBITDA
EV/Sales
Graham №$48.97

Profitability

Gross
Operating
Net 36.9%
FCF
ROE / ROIC 10.3% · —

Financial Health

Current ratio
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital

Cash Flow · TTM

Operating CF $243.53M
Capex
Free cash flow
Buybacks
Dividends paid $173.02M
Shareholder yield 4.4%

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

$48.97 vs $79.28
Trades 1.6× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings